---
$id: https://graph.org.ai/products/commodity/51131655
$type: Product
source: UNSPSC
code: "51131655"
title: "Tulopafant"
class: "51131600"
classTitle: "Anticoagulants"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tulopafant

**UNSPSC Code**: 51131655
**Class**: [Anticoagulants](Anticoagulants.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiplatelet agent with the molecular formula C25H19N3O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IQ3Q8N1287, chemically known as 1h,3h-pyrrolo(1,2-c)thiazole-7-carboxamide, n-(3-(phenylmethyl)phenyl)-3-(3-pyridinyl)-, (+)- but generally known as tulopafant, which bears US NIH Compound Identifier 65927. European Medicines Agency schedules Tulopafant in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11366MIG. The term TULOPAFANT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). TULOPAFANT is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tulopafant under HS 29349990 and SITC 51579. As of Q4 2014, TULOPAFANT remains the US FDA Preferred Term for this commodity. Tulopafant bears US NLM identifiers UMLS ID C2825687 and NCI Concept Code C81573. SMILES: S1C(N2C(C1)C(CC2)C(=O)NC1CC(CCC1)C(=O)C1CCCCC1)C1CCCNC1.

